| Nombre del producto | Canagliflozina |
|---|---|
| Número CAS | 842133-18-0 |
| Fórmula molecular | C24H25FO5S |
| Peso molecular | 444.52 |
| Apariencia | Polvo cristalino de color blanco a blanquecino |
| Ensayo (HPLC) | ≥98% |
| Pérdida por secado | ≤0,51 TP3T |
| Residuo tras la combustión | ≤0,11 TP3T |
| Metales pesados | ≤10 ppm |
| Punto de fusión | 150-155°C (dec.) |
| Rotación específica | N/A (racemic mixture) |
¿Necesitas ayuda? Póngase en contacto con nuestro equipo

Canagliflozin is the market leader in the SGLT2 inhibitor class, and it’s easy to see why: it doesn’t just lower blood sugar, it does it by sending excess glucose out through the urine, bypassing insulin entirely. That makes it a powerful tool for type 2 diabetes management, with the added perk of promoting modest weight loss and blood pressure reduction. For formulators, that’s a compelling story to tell — and a product that practically sells itself.
We supply canagliflozin as a high-purity crystalline powder, rigorously tested to meet pharmacopoeial standards. Every batch ships with a full COA, and we offer flexible packaging from 100g R&D quantities to multi-kilogram production lots. Our lead times are fast — typically 7-10 days after order — and we deliver worldwide, so you can keep your supply chain moving without a hitch.